MRC1 and neoplasm: Nanobodies (Nbs) against macrophage mannose receptor (MMR) have been developed, and their potential as in vivo diagnostic tracers for non-invasive imaging of a subpopulation of tumor-infiltrating macrophages (11, 12) and joint inflammation in rheumatoid arthritis (13) are well documented.